585 related articles for article (PubMed ID: 26417265)
21. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ; Swain A; Hubbard MA; Williams DK; Barone G; Hartsfield F; Tong Y; Carrier DJ; Cheboyina S; Battu SK
Mol Nutr Food Res; 2008 Jul; 52(7):755-63. PubMed ID: 18214849
[TBL] [Abstract][Full Text] [Related]
22. Herbal medicines and perioperative care.
Ang-Lee MK; Moss J; Yuan CS
JAMA; 2001 Jul; 286(2):208-16. PubMed ID: 11448284
[TBL] [Abstract][Full Text] [Related]
23. [Potential risks, adverse effects and drug interactions associated with herbal medicine in dental patients].
Zlotogorski Hurvitz A; Littner M
Refuat Hapeh Vehashinayim (1993); 2004 Apr; 21(2):25-41, 97. PubMed ID: 15503544
[TBL] [Abstract][Full Text] [Related]
24. Potential for interaction of kava and St. John's wort with drugs.
Singh YN
J Ethnopharmacol; 2005 Aug; 100(1-2):108-13. PubMed ID: 16005588
[TBL] [Abstract][Full Text] [Related]
25. Herbal interactions involving cytochrome p450 enzymes: a mini review.
Delgoda R; Westlake AC
Toxicol Rev; 2004; 23(4):239-49. PubMed ID: 15898829
[TBL] [Abstract][Full Text] [Related]
26. Herb-drug interactions and mechanistic and clinical considerations.
Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
[TBL] [Abstract][Full Text] [Related]
27. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
28. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies.
Mohamed ME; Frye RF
Planta Med; 2011 Mar; 77(4):311-21. PubMed ID: 21049395
[TBL] [Abstract][Full Text] [Related]
29. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
Dasgupta A
Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of St. John's wort drug interactions revisited.
Nicolussi S; Drewe J; Butterweck V; Meyer Zu Schwabedissen HE
Br J Pharmacol; 2020 Mar; 177(6):1212-1226. PubMed ID: 31742659
[TBL] [Abstract][Full Text] [Related]
31. Drug interaction between St. John's wort and cyclosporine.
Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246
[TBL] [Abstract][Full Text] [Related]
32. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
Hellum BH; Hu Z; Nilsen OG
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
[TBL] [Abstract][Full Text] [Related]
33. Herbal modulation of P-glycoprotein.
Zhou S; Lim LY; Chowbay B
Drug Metab Rev; 2004 Feb; 36(1):57-104. PubMed ID: 15072439
[TBL] [Abstract][Full Text] [Related]
34. [Herbal drug-drug interaction and adverse drug reactions].
Hafner-Blumenstiel V
Ther Umsch; 2011 Jan; 68(1):54-7. PubMed ID: 21184395
[TBL] [Abstract][Full Text] [Related]
35. Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450.
Saxena A; Tripathi KP; Roy S; Khan F; Sharma A
Bioinformation; 2008; 3(5):198-204. PubMed ID: 19255634
[TBL] [Abstract][Full Text] [Related]
36. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
[TBL] [Abstract][Full Text] [Related]
37. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products.
Hellum BH; Nilsen OG
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):466-75. PubMed ID: 18331390
[TBL] [Abstract][Full Text] [Related]
38. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
Zou L; Harkey MR; Henderson GL
Life Sci; 2002 Aug; 71(13):1579-89. PubMed ID: 12127912
[TBL] [Abstract][Full Text] [Related]
39. Dietary supplements, cytochrome metabolism, and pharmacogenetic considerations.
Matura JM; Shea LA; Bankes VA
Ir J Med Sci; 2022 Oct; 191(5):2357-2365. PubMed ID: 34734388
[TBL] [Abstract][Full Text] [Related]
40. Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.
Shord SS; Shah K; Lukose A
Integr Cancer Ther; 2009 Sep; 8(3):208-27. PubMed ID: 19815591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
